Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota

Journal of Urology

Volumn 161, Issue 2, 1999, Pages 529-533

  Roberts, Rosebud O ^a   Bergstralh, Erik J ^a   Katusic, Slavica K ^a   Lieber, Michael M ^a   Jacobsen, Steven J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Epidemiology; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; PROSTATE TUMOR; UNITED STATES;

AGED; AGED, 80 AND OVER; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MINNESOTA; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0033072813     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)61941-4     Document Type: Article

References (36)

1. Landis, S. H., Murray, T., Bolden, S. and Wingo, P. A.: Cancer statistics, 1998. Cancer J. Clin., 48: 6, 1998.
2. Boring, C. C., Squires, T. S., Tong, T. and Montgomery, S.: Cancer statistics, 1994. Cancer J. Cllin., 44: 7, 1994.
3. Mettlin, C., Jones, G., Averett, H., Gusberg, S. B. and Murphy, G. P.: Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. Cancer J. Clin., 43: 42, 1993.
4. Corder, E. H., Chute, C. G., Guess, H. A., Beard, C. M., O'Fallon, W. M. and Lieber, M. M.: Prostate cancer in Rochester, Minnesota (USA), from 1935 to 1989: increases in incidence related to more complete ascertainment. Cancer Causes Control, 5: 207, 1994.
5. Potosky, A. L., Miller, B. A., Albertsen, P. C. and Kramer, B. S.: The role of increasing detection in the rising incidence of prostate cancer. J.A.M.A., 273: 548, 1995.
6. Gilliland, F. D., Becker, T. M., Key, C. R. and Samet, J. M.: Contrasting trends of prostate cancer incidence and mortality in New Mexico's Hispanics, non-Hispanic whites, American Indians, and blacks. Cancer, 73: 2192, 1994.
7. Gilliland, F., Becker, T. M., Smith, A., Key, C. R. and Samet, J. M.: Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening. Cancer Epidemiol. Biomark. Prev., 3: 105, 1994.
8. Reynolds, T.: Prostate cancer rates climbed sharply in 1990. J. Natl. Cancer Inst., 85: 947, 1993.
9. Jacobsen, S. J., Katusic, S. K., Bergstralh, E. J., Oesterling, J. E., Ohrt, D., Klee, G. G., Chute, C. G. and Lieber, M. M.: Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. J.A.M.A., 274: 1445, 1995.
10. Demers, R. Y., Swanson, G. M., Weiss, L. K. and Kau, T-Y.: Increasing incidence of cancer of the prostate. The experience of black and white men in the Detroit metropolitan area. Arch. Intern. Med., 154: 1211, 1994.
11. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T. and Southwick, P. C.: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol., 151: 1283, 1994.
12. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J.A.M.A., 270: 948, 1993.
13. Mettlin, C., Murphy, G. P., Lee, F., Littrup, P. J., Chesley, A., Babaian, R., Badalament, R., Kane, R. A., Mostofi, F. K.: Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project. Cancer, 72: 1701, 1993.
14. Anonymous: Screening for prostate cancer: commentary on the recommendations of the Canadian Task Force on the Periodic Health Examination. The U.S. Preventive Services Task Force. Amer. J. Prev. Med., 10: 187, 1994.
15. Gohagan, J. K., Kramer, B. S. and Greenwald, P.: Screening for prostate cancer. Amer. J. Prev. Med., 10: 245, 1994.
16. Andriole, G. L. and Catalona, W. J.: Using PSA to screen for prostate cancer. The Washington University experience. Urol. Clin. N. Amer., 29: 647, 1993.
17. Catalona, W. J.: Screening for prostate cancer: enthusiasm. Urology, 42: 113, 1993.
18. Slawin, K. M., Ohori, M., Dillioglugil, O. and Scardino, P. T.: Screening for prostate cancer: an analysis of the early experience. Cancer. J. Clin., 45: 134, 1995.
19. Walsh, P. C.: Prostate cancer kills: strategy to reduce deaths. Urology, 44: 463, 1994.
20. Kurland, L. T. and Molgaard, C. A.: The patient record in epidemiology. Sci. Amer., 245: 54, 1981.
21. Melton, L. J., III: History of the Rochester Epidemiology Project. Mayo Clin. Proc., 71: 266, 1996.
22. American Joint Committee on Cancer: Manual for Staging of Cancer. Philadelphia: J. B. Lippincott Co., pp. 181-183, 1992.
23. Bergstralh, E. J., Offord, K. P., Chu, C-P., Beard, C. M., O'Fallon, W. M. and Melton, L. J., III: Calculating Incidence, Prevalence and Mortality Rates for Olmsted County, Minnesota Residents: An Update. Technical Report Series No. 49, Section of Biostatistics, Mayo Clinic, Rochester, Minnesota, April 1992.
24. Devesa, S. S., Blot, W. J., Stone, B. J., Miller, B. A., Tarone, R. E. and Fraumeni, J. F., Jr.: Recent cancer trends in the United States. J. Natl. Cancer Inst., 87: 175, 1995.
25. Newcomer, L. M., Stanford, J. L., Blumenstein, B. A. and Brawer, M. K.: Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994. J. Urol., 158: 1427, 1997.
26. Merrill, R. M. and Brawley, O. W.: Prostate cancer incidence and mortality rates among white and black men. Epidemiology, 8: 126, 1997.
27. Ries, L. A. G., Kosary, C. L., Hankey, B. F., Miller, B. A., Harras, A. and Edwards, B. K.: SEER Cancer Statistics Review, 1973-1994. National Cancer Institute, NIH Publication No. 97-2789, Bethesda, Maryland, pp. 393-404, 1997.
28. Danley, K. L., Richardson, J. L., Bernstein, L., Langholz, B. and Ross, R. K.: Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States). Cancer Causes. Control, 6: 492, 1995.
29. Hoeksema, M. J. and Law, C.: Cancer mortality rates fall: a turning point for the nation. J. Natl. Cancer. Inst., 88: 1706, 1996.
30. Stephenson, R. A. and Stanford, J. L.: Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen. World J. Urol., 15: 331, 1997.
31. Wingo, P. A., Ries, L. A. G., Rosenberg, H. M., Miller, D. S. and Edwards, B. K: Cancer incidence and mortality, 1973-1995. A report card for the U.S. Cancer, 82: 1197, 1998.
32. Kircher, T. and Anderson, R. E.: Cause of death: proper completion of the death certificate. J.A.M.A., 258: 349, 1987.
33. Carter, J. R.: The problematic death certificate. New Engl. J. Med., 313: 1285, 1985.
34. Xia, Z., Jacobsen, S. J., Bergstralh, E. J., Chute, C. G., Katusic, S. K. and Lieber, M. M.: Secular changes in radical prostatectomy utilization rates in Olmsted County, Minnesota, 1980 to 1995. J. Urol., 159: 904, 1998.
35. Jacobsen, S. J., Bergstralh, E. J., Katusic, S. K, Guess, H. A., Darby, C. H., Silverstein, M. D., Oesterling, J. E. and Lieber, M. M.: Screening digital rectal examination and prostate cancer mortality: a population-based case-control study. Urology, 52: 173, 1998.
36. Feinstein, A. R., Sosin, D. M. and Wells, C. K.: The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. New Engl. J. Med., 312: 1604, 1985.